Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Polycystic Ovary Syndrome 2 Pain 2 Obesity 2 Neoplasms 2 cyclopia sequence 1 Weight Loss 1 Vomiting 1 Vitamin D Deficiency 1 Testicular Neoplasms 1 Sleepiness 1 Sezary Syndrome 1 Primary Myelofibrosis 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pdgfra-Associated Chronic Eosinophilic Leukemia 1 Parasomnias 1 Pancreatic Cyst 1 Pain, Postoperative 1 Overweight 1 Neuroblastoma 1 Nausea 1 Myeloproliferative Disorders 1 Mycosis Fungoides 1 Multiple Myeloma 1 Metabolic Syndrome 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

Sugars 1 Metformin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Colorectum × Sugars × Clear all

NCT01550900 2013-04-05

Prospective Trial of Metformin - Chemoprevention Role

M.D. Anderson Cancer Center

Phase NA Withdrawn

Colorectum

Data powered by HemOnc (CC BY 4.0) Colophon ⚡